Center for Biopharmaceuticals & Department of Drug Design and Pharmacology, University of Copenhagen, Universitetsparken 2, 2100, Copenhagen, Denmark.
Universität Bayreuth, Lehrstuhl Biochemie und Forschungszentrum für Biomakromoleküle, Universitätsstrasse 30, 95447, Bayreuth, Germany.
Angew Chem Int Ed Engl. 2017 Nov 20;56(47):14836-14841. doi: 10.1002/anie.201709050. Epub 2017 Nov 2.
The sirtuin enzymes are important regulatory deacylases in a variety of biochemical contexts and may therefore be potential therapeutic targets through either activation or inhibition by small molecules. Here, we describe the discovery of the most potent inhibitor of sirtuin 5 (SIRT5) reported to date. We provide rationalization of the mode of binding by solving co-crystal structures of selected inhibitors in complex with both human and zebrafish SIRT5, which provide insight for future optimization of inhibitors with more "drug-like" properties. Importantly, enzyme kinetic evaluation revealed a slow, tight-binding mechanism of inhibition, which is unprecedented for SIRT5. This is important information when applying inhibitors to probe mechanisms in biology.
去乙酰化酶 sirtuins 是多种生化环境中重要的调节去乙酰化酶,因此,通过小分子激活或抑制,它们可能成为潜在的治疗靶点。在这里,我们描述了迄今为止报道的 sirtuin 5 (SIRT5) 的最有效抑制剂的发现。我们通过解析选定抑制剂与人和斑马鱼 SIRT5 复合物的共晶结构,对结合模式进行了合理化解释,为未来具有更多“类药性”特性的抑制剂的优化提供了思路。重要的是,酶动力学评估揭示了抑制的缓慢、紧密结合机制,这在 SIRT5 中是前所未有的。当应用抑制剂来探索生物学中的机制时,这是一个重要的信息。